Moody's

NEW YORK (GenomeWeb News) – Agilent Technologies priced its public offering of senior notes at an aggregate principal amount of $400 million after the close of the market on Monday. The notes will mature in October 2022 and bear interest at an annual rate of 3.20 percent.

NEW YORK (GenomeWeb News) – Following Thermo Fisher Scientific's announcement today that it is buying One Lambda for $925 million, ratings agency Moody's Investors Service downgraded the company's s

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Moody's Investors Service has upgraded $2.3 billion of Life Technologies' Senior Unsecured Notes to investment grade from speculative grade.

Earlier this month the California Institute for Regenerative Medicine said it plans to privately sell $200 million in bonds in this and the following fiscal year in case it will be unable to access public capital.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.